Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR

Published:2024-07-17 Issue: Volume: Page:
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Mei Mei,Zeng Jun,Fang Li,Xiang Sha,Sun Haili,Wen Chaolin,Chai Liyin,Chen Xinqing,Li Zhuhong,Li Ning,Shen Bingbing

Funder

Chongqing Natural Science Foundation Project

Chongqing Science and health joint medical research Project

Chongqing University Central Hospital Scientific Research Foundation

Chongqing Science and Health United Traditional Chinese Medicine Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11255-024-04156-9.pdf

Reference31 articles.

1. Wen CP, Chang CH, Tsai MK, Lee JH, Lu PJ, Tsai SP et al (2017) Diabetes with early kidney involvement may shorten life expectancy by 16 years. Kidney Int 92(2):388–396

2. Chen Y, Lee K, Ni Z, He JC (2020) Diabetic kidney disease: challenges, advances, and opportunities. Kidney Dis (Basel, Switz) 6(4):215–225

3. Raval N, Kumawat A, Kalyane D, Kalia K, Tekade RK (2020) Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities. Drug Discov Today 25(5):862–878

4. Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295–2306

5. Vergara A, Jacobs-Cacha C, Llorens-Cebria C, Ortiz A, Martinez-Diaz I, Martos N et al (2022) Enhanced cardiorenal protective effects of combining SGLT2 inhibition, endothelin receptor antagonism and RAS blockade in type 2 diabetic mice. Int J Mol Sci. https://doi.org/10.3390/ijms232112823

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3